GCS Project Home › Forum › Available Clinical Trials › NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors › Reply To: NCT02834013 Nivolumab and Ipilimumab in Treating Patients With Rare Tumors
I am not looking at trial yet…just started on carbo/taxol regimen every 21 days x 6 cycles 1/5/18. Almost all trials for MMMT require prior therapy.
I just met with a MedOnc about the aforementioned trial today should I need it. Just wanted to get established as a new pt to expedite in case.
The GCS Project is dedicated to finding a cure for Gynecological Carcinosarcoma (aka MMMT), providing current scientifically valid information, and offering a place for the community impacted by this cancer to share stories and hope.
© 2021 GCS Project